Flagship Harbor Advisors’s Bausch Health BHC Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
Sell
-61
Closed -$424 875
2025
Q4
$424 Buy
+61
New +$401 ﹤0.01% 2064
2020
Q4
Sell
-111
Closed -$1K 659
2020
Q3
$1K Hold
111
﹤0.01% 1791
2020
Q2
$2K Hold
111
﹤0.01% 1792
2020
Q1
$2K Hold
111
﹤0.01% 1620
2019
Q4
$3K Buy
111
+60
+118% +$1.56K ﹤0.01% 1624
2019
Q3
$1K Hold
51
﹤0.01% 1734
2019
Q2
$1K Hold
51
﹤0.01% 1750
2019
Q1
$1K Hold
51
﹤0.01% 1738
2018
Q4
$0 Hold
51
﹤0.01% 1850
2018
Q3
$1K Sell
51
-50
-50% -$1.15K ﹤0.01% 1968
2018
Q2
$2K Buy
+101
New +$2.09K ﹤0.01% 1831

Other funds holding BHC

Flagship Harbor Advisors's BHC Position: Q1 2026 in Review

Flagship Harbor Advisors sold out of Bausch Health (BHC) in Q1 2026, closing a stake of 61 shares — an estimated $424 sold.

Flagship Harbor Advisors first reported a position in BHC in Q2 2018 and held it in 11 quarters. The position peaked at $3K in Q4 2019. 227 funds tracked by Wall St. Rank hold BHC as of Q1 2026.

  • Flagship Harbor Advisors reported no remaining Bausch Health position as of Q1 2026 after selling out during the quarter.
  • Flagship Harbor Advisors sold 61 Bausch Health shares in Q1 2026, an estimated $424.
  • Flagship Harbor Advisors first reported a position in Bausch Health in Q2 2018 and held it in 11 quarters.
  • Flagship Harbor Advisors's Bausch Health position peaked at $3K in Q4 2019.
  • 227 funds tracked by Wall St. Rank held Bausch Health as of Q1 2026.

Based on Flagship Harbor Advisors's 13F filing for Q1 2026, filed 28 Apr 2026.